Researchers have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer patients.

Researchers from the University of Michigan have developed a way of detecting circulating tumor cells in the bloodstream of ...

In an extremely rare case, an unnamed 69-year-old man who had cirrhosis and liver cancer underwent a liver transplant and ...

In an extremely rare case, an unnamed 69-year-old man who had cirrhosis and liver cancer underwent a liver transplant and ...

Though lung cancer survival rates are improving, lung cancer is still the leading cause of cancer deaths in the US.

Faye Louise, a former model, recovered from cancer after having eight organs removed due to a rare tumor called pseudomyxoma ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. | In this tracker, Fierce Pharma is recording the ...

Significant advancements in lung cancer treatment were seen throughout 2024, from new drug approvals to promising clinical ...

Lung cancer, notorious for its high mortality rates, is a leading cause of cancer-related deaths globally, with metastasis being the primary contributor to poor patient outcomes.

Faye Louise was diagnosed with a rare cancer that often requires multiple organs to be removed via surgery — but one year ...

Cemiplimab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Penile Cancer.